AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Applied Materials
AMAT
|
+$1.11B |
| 2 |
Walt Disney
DIS
|
+$920M |
| 3 |
ILOW
AB International Low Volatility Equity ETF
ILOW
|
+$784M |
| 4 |
Broadcom
AVGO
|
+$771M |
| 5 |
United Rentals
URI
|
+$751M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$1.19B |
| 2 |
NVIDIA
NVDA
|
+$998M |
| 3 |
Edwards Lifesciences
EW
|
+$881M |
| 4 |
CrowdStrike
CRWD
|
+$663M |
| 5 |
Adobe
ADBE
|
+$599M |
Sector Composition
| 1 | Technology | 28.34% |
| 2 | Healthcare | 15.32% |
| 3 | Consumer Discretionary | 10.78% |
| 4 | Financials | 9.64% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Design Therapeutics
DSGN
$371M
| $226K | ﹤0.01% |
42,090
| – | – |
|
3002
Vanguard Consumer Discretionary ETF
VCR
$6.51B
| $225K | ﹤0.01% |
661
| – | – |
|
3003
Alta Equipment Group
ALTG
$254M
| $225K | ﹤0.01% |
33,310
+3,610
| +12% | +$24.3K |
|
3004
Jakks Pacific
JAKK
$196M
| $223K | ﹤0.01% |
+8,730
| New | +$223K |
|
3005
Liberty Live Group Series A
LLYVA
$8.94B
| $222K | ﹤0.01% |
+4,491
| New | +$222K |
|
|
LENZ
3006
LENZ Therapeutics
LENZ
$1.12B
| $222K | ﹤0.01% |
+9,346
| New | +$222K |
|
3007
Ventyx Biosciences
VTYX
$171M
| $221K | ﹤0.01% |
101,330
| – | – |
|
3008
TotalEnergies
TTE
$135B
| $220K | ﹤0.01% |
+3,407
| New | +$220K |
|
3009
The Beauty Health Co
SKIN
$304M
| $219K | ﹤0.01% |
152,380
+12,340
| +9% | +$17.8K |
|
3010
InnovAge Holding
INNV
$550M
| $218K | ﹤0.01% |
36,300
| – | – |
|
|
FDSB
3011
Fifth District Bancorp, Inc. Common Stock
FDSB
$77.5M
| $218K | ﹤0.01% |
+20,990
| New | +$218K |
|
3012
Taysha Gene Therapies
TSHA
$900M
| $218K | ﹤0.01% |
108,250
+12,650
| +13% | +$25.4K |
|
3013
Solid Power
SLDP
$673M
| $217K | ﹤0.01% |
160,750
| – | – |
|
3014
Larimar Therapeutics
LRMR
$328M
| $217K | ﹤0.01% |
33,060
+5,270
| +19% | +$34.5K |
|
3015
Central Garden & Pet
CENT
$2.33B
| $216K | ﹤0.01% |
+5,920
| New | +$216K |
|
3016
Voyager Therapeutics
VYGR
$217M
| $215K | ﹤0.01% |
36,750
| – | – |
|
3017
Precigen
PGEN
$1.2B
| $215K | ﹤0.01% |
226,660
| – | – |
|
3018
AudioEye
AEYE
$167M
| $214K | ﹤0.01% |
+9,380
| New | +$214K |
|
3019
B. Riley Financial
RILY
$161M
| $213K | ﹤0.01% |
40,574
+11,990
| +42% | +$62.9K |
|
|
PDS
3020
Precision Drilling
PDS
$760M
| $213K | ﹤0.01% |
3,449
+2,349
| +214% | +$145K |
|
3021
Aura Biosciences
AURA
$399M
| $212K | ﹤0.01% |
23,820
+1,450
| +6% | +$12.9K |
|
3022
Eventbrite
EB
$264M
| $212K | ﹤0.01% |
77,500
| – | – |
|
3023
Tucows
TCX
$198M
| $211K | ﹤0.01% |
10,090
| – | – |
|
3024
MeiraGTx Holdings
MGTX
$601M
| $210K | ﹤0.01% |
50,390
| – | – |
|
3025
Ouster
OUST
$1.63B
| $210K | ﹤0.01% |
33,300
+10,490
| +46% | +$66.1K |
|